CNO Financial Group (CNO)
(Delayed Data from NYSE)
$34.97 USD
+0.57 (1.66%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $34.98 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth F Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$34.97 USD
+0.57 (1.66%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $34.98 +0.01 (0.03%) 7:58 PM ET
2-Buy of 5 2
A Value D Growth F Momentum C VGM
Zacks News
Here's Why You Should Hold on to Marsh & McLennan Stock for Now
by Zacks Equity Research
MMC is well-poised on sustained top-line growth, rate hikes and prudent deployment of capital.
Should Value Investors Buy CNO Financial Group (CNO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
CNO Financial's Washington National Enhances Insurance Product
by Zacks Equity Research
CNO enhances its Hospital Indemnity Insurance product in a bid to enhance offerings and improve retention.
CNO Financial (CNO) is a Great Momentum Stock: Should You Buy?
by Zacks Equity Research
Does CNO Financial (CNO) have what it takes to be a top stock pick for momentum investors? Let's find out.
Everest Group Stock Lags Industry YTD: Should You Hold or Fold?
by Zacks Equity Research
Strong renewal retention, continued favorable rate increases, financial flexibility and prudent capital deployment poise EG for growth.
Analyzing MetLife Stock: Is Buy Strategy the Right Move?
by Zacks Equity Research
MET remains well-poised for growth, attributed to strength in the EMEA segment, divestiture of underperforming businesses and a commendable financial stand.
CNO Financial Up 19.6% in 3 Months: Will You Regret Not Buying in?
by Zacks Equity Research
CNO invests significantly in technology to improve agent productivity and sales.
CNO (CNO) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
by Zacks Equity Research
CNO (CNO) appears to have found support after losing some value lately, as indicated by the formation of a hammer chart. In addition to this technical chart pattern, strong agreement among Wall Street analysts in revising earnings estimates higher enhances the stock's potential for a turnaround in the near term.
Are Investors Undervaluing CNO Financial Group (CNO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Radian (RDN) Up 0.7% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Radian (RDN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
CNO (CNO) Down 1.4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
CNO (CNO) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Here's Why Aflac Stock is a Smart Addition to Your Portfolio
by Zacks Equity Research
AFL remains well-poised for growth on productivity improvements in its U.S. business, product launches and sound operating cash flows.
Should Value Investors Buy CNO Financial Group (CNO) Stock?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Lincoln National (LNC) Starts Grief Support for Group Life Clients
by Zacks Equity Research
Lincoln National (LNC) enhances its Group Life insurance policies with Empathy's grief support services, and offering personalized and legal assistance.
What Makes CNO Financial (CNO) a Strong Momentum Stock: Buy Now?
by Zacks Equity Research
Does CNO Financial (CNO) have what it takes to be a top stock pick for momentum investors? Let's find out.
MGIC Investment (MTG) Gains 24% YTD: More Room for Growth?
by Zacks Equity Research
MGIC Investment (MTG) is set to grow on solid insurance in force, a decline in loss and claims payments, lower delinquency, better housing market fundamentals and prudent capital deployment.
Radian (RDN) Gains 21% YTD: Will It Retain the Bull Run?
by Zacks Equity Research
Radian (RDN) looks poised for growth on solid insurance in force, a decline in loss and claims payments and lower delinquency.
New Strong Buy Stocks for August 15th
by Zacks Equity Research
NREF, SWIM, NRILY, CNO and AXS have been added to the Zacks Rank #1 (Strong Buy) List on August 15, 2024.
Best Value Stocks to Buy for August 15th
by Zacks Equity Research
CNO and MCRI made it to the Zacks Rank #1 (Strong Buy) value stocks list on August 15, 2024.
eHealth (EHTH) Incurs Q2 Loss on Weak Employer and Individual Unit
by Zacks Equity Research
eHealth's (EHTH) second-quarter results reflect higher marketing costs. The Medicare segment performed well while the Employer and Individual segment suffered a setback.
Are Investors Undervaluing CNO Financial Group (CNO) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Are You Looking for a High-Growth Dividend Stock?
by Zacks Equity Research
Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does CNO Financial (CNO) have what it takes? Let's find out.
EverQuote (EVER) Q2 Earnings Top on Solid Automotive Revenues
by Zacks Equity Research
EverQuote (EVER) Q2 results reflect solid performances across both Automotive insurance and Home and Renters insurance verticals and increased variable marketing margin, offset by higher expenses.
Here's Why CNO Financial (CNO) is a Strong Momentum Stock
by Zacks Equity Research
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
MetLife (MET) Q2 Earnings Beat on Favorable Underwriting Results
by Zacks Equity Research
MetLife's (MET) second-quarter 2024 results benefit from improved variable investment income, strong volumes and strength in the Group Benefits segment. However, poor performance in the RIS segment partially offset the results.